PPARγ, as a modulator of cellular differentiation and regulator of tumorigenesis, was found to be expressed in many different types of cancer cells and its activation by agonists leads to either cell proliferation inhibition or cancel cell apoptosis [82,83]. The gene discussed is PPARG; the disease is cancer.